Search

Displaying results 2241 - 2250 of 9700 in total
  1. Drug

    Belfosdil

    go.drugbank.com/drugs/DB21327
    Experimental

    Belfosdil is a small molecule drug. The usage of the INN stem '-dil' in the name indicates that Belfosdil is a vasodilator. Belfosdil has a monoisotopic molecular weight of 548.3 Da.

  2. Drug

    Litomeglovir

    go.drugbank.com/drugs/DB21363
    Experimental

    Litomeglovir is a small molecule drug. The usage of the INN stem '-vir' in the name indicates that Litomeglovir is a antiviral. Litomeglovir has a monoisotopic molecular weight of 498.19 Da.

  3. Drug

    Norgesterone

    go.drugbank.com/drugs/DB21409
    Experimental

    Norgesterone is a small molecule drug. The usage of the INN stem '-terone' in the name indicates that Norgesterone is a antiandrogen. Norgesterone has a monoisotopic molecular weight of 300.21 Da.

  4. Drug

    Pitenodil

    go.drugbank.com/drugs/DB21442
    Experimental

    Pitenodil is a small molecule drug. The usage of the INN stem '-dil' in the name indicates that Pitenodil is a vasodilator. Pitenodil has a monoisotopic molecular weight of 353.18 Da.

  5. Drug

    Levothyroxine

    go.drugbank.com/drugs/DB00451
    ApprovedInvestigational

    Levothyroxine is a synthetically produced form of thyroxine, a major endogenous hormone secreted by the thyroid gland. … [F4633] Also known as L-thyroxine or the brand name product Synthroid, levothyroxine is used primarily to treat hypothyroidism, a condition where the thyroid gland is no longer able to produce sufficient

    Synonyms: L-T4, L-ThyroxineMixtures: L THYROX JOD HEXAL 50/150, L THYROX JOD HEXAL 50/150
  6. Drug

    MLN-977

    go.drugbank.com/drugs/DB05431
    Experimental

    MLN-977 is a small molecule compound that inhibits the production of leukotrienes, especially 5-lipoxygenase. It is developed by PharmaEngine to treat asthma and chronic obstructive pulmonary disease.

  7. Drug

    Remetinostat

    go.drugbank.com/drugs/DB14869
    Investigational

    Remetinostat is under investigation in clinical trial NCT02213861 (Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma).

  8. Drug

    Velufenacin

    go.drugbank.com/drugs/DB21473
    Investigational

    Velufenacin has a monoisotopic molecular weight of 362.12 Da. … Velufenacin is a small molecule drug. The usage of the INN stem '-fenacin' in the name indicates that Velufenacin is a muscarinic receptor antagonist.

  9. Drug

    R906289

    go.drugbank.com/drugs/DB19126
    Investigational

    R906289 is under investigation in clinical trial NCT05308264 (Study of R289 in Participants With Lower-risk Myelodysplastic Syndromes (LR MDS)).

  10. Drug

    Cabergoline

    go.drugbank.com/drugs/DB00248
    ApprovedInvestigational

    Cabergoline, an ergot derivative, is a long-acting dopamine agonist and prolactin inhibitor. It is used to treat hyperprolactinemic disorders and Parkinsonian Syndrome.

    Categories: P-glycoprotein substrates with a Narrow Therapeutic Index, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic IndexProducts: CABERGOLIN-1A PHARMA1MG, CABERGOLIN-1A PHARMA2MG